retinaint.bsky.social
@retinaint.bsky.social
For World Sight Day this year, our priority is to #KeepPatientsVoting.

We are proud to launch our campaign, Patient Voices: Deciding Our Futures.

Learn more: https://ow.ly/s3X250X7MoU

#WorldSightDay #PatientVoices #WSD2025
October 8, 2025 at 7:05 PM
Have you registered for our free World Sight Day webinar, The Patient Voice and Innovation:

🗓️ Date: October 9
⏱️ Time: 1:30 PM UK | 2:30 PM CET | 8:30 AM EDT
⌛ Duration: 1 hour

us06web.zoom.us/meeting/regi...

#Webinar #WSD2025 #FreeEvent #Ophthalmology #PatientVoice
Welcome! You are invited to join a meeting: Retina International on World Sight Day: The Patient Voice and Innovation. After registering, you will receive a confirmation email about joining the meetin...
Welcome! You are invited to join a meeting: Retina International on World Sight Day: The Patient Voice and Innovation. After registering, you will receive a confirmation email about joining the meetin...
us06web.zoom.us
October 7, 2025 at 1:52 PM
Reposted
September 16, 2025 at 1:10 PM
Are you a young person living with a retinal condition? Register today for the Retina International Youth World Conference! Saturday, September 27 at 4pm CET> us06web.zoom.us/meeting/regi... #Conference #Science #Retina #RetinaYouth
September 9, 2025 at 8:08 AM
Reposted
Re-Vana is pleased to announce that our CEO, Michael O’Rourke, will present at Ophthalmology Futures Forums Retina 2025 (Panel 3: Neovascular AMD) and at the EURETINA Innovation Spotlight 2025 (Rapid Fire Panel Presentation and Discussion) on Wed, Sept 3 in Paris. #OFF2025 #EIS2025
August 30, 2025 at 8:11 AM
We're excited to attend @euretina.bsky.social!

➡️ Our abstract details:
“Can large language models improve the readability of online patient education materials on retinal diseases?”

📍 6th September 2025
🕤 10:00 – 10:06
📌Speakers' Corner 18

@avrilbdaly.bsky.social @nabinpaudel.bsky.social
September 3, 2025 at 11:05 AM
Join us at @euretina.bsky.social! We will be presenting our latest work, "Can large language models improve the readability of online patient education materials on retinal diseases?”

🗓 Speakers’ Corner 18: Miscellaneous
⏰ 09:30–10:30 CEST | Dr. Nabin Paudel speaking 10:00–10:06

#EURETINA #RI
August 14, 2025 at 10:27 AM
Save the date! Our Head of Research, Dr. @nabinpaudel.bsky.social will speak at #EURETINA2025 on AI and clearer patient info for retinal diseases.
- Sept 6, 10:00 CEST.
#Ophthalmology #AI #EURETINA25 @euretina.bsky.social
July 2, 2025 at 9:41 AM
Exciting news! Our colleague Dr. @nabinpaudel.bsky.social will present at @euretina.bsky.social #EURETINA25 on using AI to improve the readability of online patient education materials on retinal diseases. Save the date! Sept 6 at 10:00 CEST
#AIinHealthcare retina-international.org/ri-euretina-...
Retina International
retina-international.org
June 19, 2025 at 11:30 AM
Congrats to Prof. José-Alain Sahel, Co-chair of our SMAB, on receiving the @arvoinfo.bsky.social Proctor Medal for his pioneering work in retinal research.

This is one of the highest honors bestowed by ARVO - and so well deserved.

#ProctorMedal #ARVO #Award #RetinalResearch #Retina #Research
June 18, 2025 at 9:04 AM
Thanks to all who joined our #ARVO #SIG on #GA trial endpoints yesterday - great insights from regulators, industry, academia & the patient community.

More multistakeholder conversations to come!
June 11, 2025 at 11:11 AM
Our @arvoinfo.bsky.social #SIG on GA trial endpoints is today. Join global experts + patient voices to rethink what meaningful outcomes look like.
Last chance to register! www.arvo.org/education/sp...
@avrilbdaly.bsky.social @nabinpaudel.bsky.social #GeographicAtrophy #ClinicalTrials
June 10, 2025 at 9:40 AM
Our @arvoinfo.bsky.social #SIG on #GeographicAtrophy endpoints is just 2 weeks away. Join us on June 10 to help shape more meaningful trial outcomes.
🔗 Register today! www.arvo.org/education/sp...
@avrilbdaly.bsky.social @nabinpaudel.bsky.social @ema.europa.eu #GeographicAtrophy #ClinicalTrials
May 29, 2025 at 10:53 AM
Retina International welcomes this step forward for our community. We thank @rarediseasesint.bsky.social for its leadership in bringing together patient reps from around the world and for ensuring that our voices are heard loud and clear at the global level. #Resolution4Rare #RareEyeDiseases #IRDs
🎉 BREAKING NEWS FROM GENEVA! 🎉

The Resolution on Rare Diseases has officially been adopted at the 78th World Health Assembly (WHA78)! 🌍✅

#WHA78 #RareDiseases #HealthForAll #Equity #UHC #Resolution4Rare
May 26, 2025 at 10:33 AM
Reposted
Huge achievement for all in the #global #raredisease community & an example that successful collaboration across borders, cultures, languages and systems, is absolutely possible if we listen & learn from each other. Well done to everyone involved! #HealthforaAll #Resolution4Rare #UHC #WHA78
🎉 BREAKING NEWS FROM GENEVA! 🎉

The Resolution on Rare Diseases has officially been adopted at the 78th World Health Assembly (WHA78)! 🌍✅

#WHA78 #RareDiseases #HealthForAll #Equity #UHC #Resolution4Rare
May 24, 2025 at 2:45 PM
Reposted
🎉 BREAKING NEWS FROM GENEVA! 🎉

The Resolution on Rare Diseases has officially been adopted at the 78th World Health Assembly (WHA78)! 🌍✅

#WHA78 #RareDiseases #HealthForAll #Equity #UHC #Resolution4Rare
May 24, 2025 at 10:03 AM
Our CEO @avrilbdaly.bsky.social, in her role as President of @eurordis.bsky.social, opened the EURORDIS Membership Meeting 2025 in Riga 🇱🇻 #EMM2025

The theme: Maximising our impact - Strengthening the voice of the rare disease community in decision-making.

#RareDiseases #EURORDIS #PatientVoice
May 23, 2025 at 8:50 AM
How do we make GA clinical trials more patient-focused?
Join our virtual @arvoinfo.bsky.social SIG session:

June 10, 9-10:30am EDT.

Hosted by @retinaint.bsky.social - open discussion encouraged!

🔗 Register: www.arvo.org/education/sp...

#GeographicAtrophy #RetinaResearch #ClinicalTrials #AMD
May 21, 2025 at 9:59 AM
Reposted
ENGAGED is a joint project run between @tcddublin.bsky.social and @dublincityuni.bsky.social funded by the National Open Research Forum (NORF), a Government of Ireland initiative, funded by the Dept of Further and Higher Education, Research, Innovation and Science
#OpenResearch #PublicEngagement
May 12, 2025 at 9:09 PM
We warmly welcome the @ema.europa.eu CHMP’s positive opinion on the first targeted therapy for Thyroid Eye Disease (TED).

🔗 Read more: retina-international.org/ted-press-re...

#RareDisease #TED #RetinaInternational #VisionHealth #InnovationInSight @amgen.bsky.social @avrilbdaly.bsky.social
May 12, 2025 at 9:42 AM
We're delighted to have had such a productive few days at #ARVO2025 @arvoinfo.bsky.social this year. Dr @nabinpaudel.bsky.social & @avrilbdaly.bsky.social presented work that demonstrates our commitment to patient-driven, evidence-based innovation. So many interesting discussions! More to follow!
May 7, 2025 at 11:29 AM
Attending @arvoinfo.bsky.social #ARVO2025? Don't miss our Head of Research & Programmes Dr @nabinpaudel.bsky.social: Accuracy and readability of ChatGPT-4o responses to patient queries on AMD.

📌Large language models in Ophthalmology
📅 May 6, 2025 | 3:30PM - 5:15PM
📍 Posterboard Number: 3952 - B0489
May 6, 2025 at 2:07 PM
Productive day for us @arvoinfo.bsky.social - our CEO @avrilbdaly.bsky.social presented her work on #GA and Dr @nabinpaudel.bsky.social will present on Tuesday. At ARVO? Come find us to chat more about our work: ℹ️ www.linkedin.com/posts/retina... #ARVO2025 #ARVO #EyeResearch #Ophthalmology
May 4, 2025 at 8:50 PM
At Retina International, our newsletter isn’t just news, it’s a global connection. A place where patients, researchers, advocates, and allies come together to share, learn, and lead change in retinal health.
➡️ Read our April edition here: bit.ly/4cNCvUU.
➡️ Subscribe here: bit.ly/4cGXVmt
#RetinaIntl
April 23, 2025 at 11:19 AM
Late-stage #AMD isn’t just a health issue, it’s an economic one.
New research led by Dr. @Nabin Paudel @retinaint.bsky.social, shows massive costs in 🇧🇬 🇩🇪 🇺🇸, with lost well-being & productivity driving the burden. Early action matters. Read more:
🔗 www.ophthalmologytimes.com/view/economi... #DMAE
April 16, 2025 at 12:10 PM